- Home
- FENC vs PFL Comparison
FENC vs PFL Comparison
Compare FENC & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$11.85
Company Overview
Basic Information| Metric | FENC | PFL |
|---|---|---|
| Founded | 1996 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.0M | 395.7M |
| IPO Year | 2010 | 2003 |
Fundamental Metrics
Financial Performance| Metric | FENC | PFL |
|---|---|---|
| Price | $11.85 | $7.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 166.1K | 144.8K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $65.12 | N/A |
| Revenue Next Year | $41.08 | N/A |
| P/E Ratio | $197.83 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $7.52 |
| 52 Week High | $13.25 | $8.70 |
Technical Indicators
Market Signals| Indicator | FENC | PFL |
|---|---|---|
| Relative Strength Index (RSI) | 60.19 | 38.02 |
| Support Level | $9.74 | $7.62 |
| Resistance Level | N/A | $7.89 |
| Average True Range (ATR) | 0.72 | 0.07 |
| MACD | 0.13 | -0.01 |
| Stochastic Oscillator | 66.79 | 7.78 |
Price Performance
Historical Comparison FENC
PFL
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. The company seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.